About nContact
nContact is a company based in Morrisville (United States) founded in 2005 was acquired by AtriCure in October 2015. nContact has raised $67.67 million across 8 funding rounds from investors including AtriCure, Hercules Capital and Harbert Management. The company has 14 employees as of December 31, 2015. nContact operates in a competitive market with competitors including AtriCure, AtaCor Medical, Kestra Medical Technologies, CardioFocus and Biosense Webster, among others.
- Headquarter Morrisville, United States
- Employees 14 as on 31 Dec, 2015
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Ncontact Surgical, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of nContact
nContact has successfully raised a total of $67.67M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $20 million completed in November 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in nContact
nContact has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include AtriCure, Hercules Capital and Harbert Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt financing is provided to companies in multiple sectors.
|
Locked | Locked | Locked | |
|
Infrastructure, hedge, private equity, and debt fund focused on multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for nContact
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by nContact
Investment portfolio details for nContact
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - nContact
Detailed financials for nContact
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ncontact Comparisons
Peer comparison for nContact
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of nContact
nContact operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtriCure, AtaCor Medical, Kestra Medical Technologies, CardioFocus and Biosense Webster, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| Locked | Locked | Locked |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| Locked | Locked | Locked |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| Locked | Locked | Locked |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| Locked | Locked | Locked |
Mapping catheters for cardiac arrhythmia treatment are developed.
|
|
| Locked | Locked | Locked |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
Detailed competitors of nContact
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ncontact
Complete news archive for nContact
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about nContact
nContact was founded in 2005 and raised its 1st funding round 1 year after it was founded.
nContact is headquartered in Morrisville, United States.
nContact is a funded company, having raised a total of $67.67M across 8 funding rounds to date.
As of Dec 31, 2015, the latest employee count at nContact is 14.
nContant has developed the EPi-Sense and Numeris Coagulation System and VisiTrax epicardial ablation device for treatment of atrial fibrillation. The EPi-Sense and Numeris Coagulation System with VisiTrax have CE Mark Approval in Europe for the coagulation of cardiac tissue for the treatment of atrial fibrillation and atrial flutter. It integrates suction, perfusion, and radiofrequency energy to ensure cardiac tissue contact and energy transmission to create linear lesions on a beating heart. Numeris with VisiTrax is also indicated for endoscopic coagulation of cardiac tissue in the United States.
nContact's top competitors include AtaCor Medical, AtriCure and CardioFocus.
nContact has 8 investors. Key investors include AtriCure, Hercules Capital, Harbert Management, Finistere Ventures, and Intersouth Partners.